Eli Lily: Intriguing COVID-19 Story, but Questions Remain
Regeneron joins Lilly in seeking emergency OK for COVID-19 antibody
EU’s potential Covid-19 vaccine doses top a billion with J&J deal
Easyjet foresees losses in 2020 close to 1 billion euros
US Q3 GDP Expected To Rise Sharply As Q4 Outlook Dims
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jab
Gilead vs Pfizer: Which Healthcare Stock Has Stronger Prospects?
Suncor To Layoff Up To 15% Of Staff Amid Challenging Conditions
Gold Prices Supported By Western Investors As Consumer Demand In China And India Slows
European regulators begin rolling review of AZ’s COVID-19 vaccine
EMA review of AZ’s COVID-19 vaccine imminent; report
Eli Lilly to continue other Covid-19 antibody drug trials after pausing one on safety concerns
"Contested Election" It Is: Here Is How To Trade It
Moderna Covid-19 vaccine appears safe, shows signs of working in older adults – study
Nasdaq-listed Bitcoin miner hit by coronavirus, records a 50% drop in revenue
Scientists urge Pfizer to delay COVID-19 vaccine filing
Kits and reagents and viruses
CytoDyn: After FDA Requests More Data On COVID-19 Treatment, This Analyst Remains Sidelined
Novavax teases Covid-19 vaccine trial design as it kicks off UK study — US to follow next month
Initial jobless claims rise slightly, while continuing claims decline - both at still awful levels
United becomes first US carrier to introduce rapid COVID-19 tests
5 reasons mortgage rates will rise in 2021
Fujifilm’s Avigan shown to be effective in Japanese Phase-3 trial for Covid-19
Carnival To Sell Two Princess Cruises Ships; Street Stays Firmly Sidelined
Moderna Reveals Efficacy Criteria For Key Covid-19 Vaccine Trials
U.S. plans for hundreds of millions of cheap, fast Covid-19 tests
Novavax Inks Deal With India For 2B Covid-19 Vaccine Doses In 2021
AstraZeneca’s Pivotal Covid-19 Vaccine Trial Kept On Hold In US- Report
Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
UBS Downgrades Expedia To Hold On Travel Demand Concerns; Shares Fall